iSpecimen Supports Hospital in Validation of New Chemistry Analyzer

iSpecimen, a provider of human biospecimens, has supported a hospital laboratory in the validation of a new chemistry analyzer for clinical use. The project, which began in September 2026, involves the collection of more than 1,700 serum, plasma, cerebrospinal fluid (CSF), and urine specimens from a healthcare system already using the same analyzer. These specimens will be used to evaluate the analyzer's performance across multiple specimen types and result ranges, ensuring the hospital can bring new testing capabilities to its patients.

The collaboration between iSpecimen and the hospital began when iSpecimen identified a healthcare system with experience using the analyzer. This system was tasked with collecting the necessary specimens, which are now being managed by iSpecimen to support the hospital's validation process.

The project reflects iSpecimen's capabilities in specialized biospecimen sourcing for laboratory technologies and its commitment to various healthcare organizations. Through its network of healthcare institutions, laboratories, biobanks, and research partners, the company provides access to human biospecimens for laboratory validation, assay development, research, and other applications. iSpecimen maintains a domestic and global network of healthcare institutions, laboratories, biobanks, and research partners that supports the sourcing of specialized biospecimens for laboratory validation and other applications.

The hospital will use the collected specimens to complete its validation process before commencing clinical testing with the analyzer. Specimen collection remains ongoing, while iSpecimen will continue to manage the project between the two organizations. The hospital's validation process is crucial for ensuring the accuracy and reliability of the new chemistry analyzer, which will ultimately benefit patient care.

This project underscores iSpecimen's role in facilitating the integration of new technologies into clinical practice. By providing the necessary biospecimens, iSpecimen ensures that hospitals can validate new analyzers and bring advanced testing capabilities to their patients. The company's network and expertise in biospecimen sourcing are instrumental in supporting the validation process, which is essential for the adoption of new medical technologies.